BIOMAT Database Logo BIOMAT Database Logo

Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy. 2021

Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

Lactic acid in the tumor microenvironment is highly correlated with the prognosis of tumor chemoembolization, but there are limited clinical strategies to deal with it. To improve the efficacy, NaHCO3 nanoparticles are innovatively introduced into drug-loaded microspheres to neutralize lactic acid in the tumor microenvironment. Here we showed that multifunctional ethyl cellulose microspheres dual-loaded with doxorubicin (DOX) and NaHCO3 nanoparticles (DOX/NaHCO3-MS) presented excellent antitumor effects by improving the pH of the tumor microenvironment. The homeostasis of the tumor microenvironment was continuously disturbed due to the sustained release of NaHCO3 nanoparticles, which also led to a significant increase in tumor cell apoptosis (compared with the control and DOX-MS groups). We also showed that the administration of DOX/NaHCO3-MS via the hepatic artery in a rabbit model of VX2 orthotopic liver cancer resulted in optimal antitumor efficacy, and the area of tumor necrosis at the embolization site was significantly increased and the proliferation of tumor cells was significantly weakened. The designed DOX/NaHCO3-MS exhibited strong synergistic antitumor effects of embolization, chemotherapy, and tumor microenvironment improvement. The present microspheres provided a strategy for the enhancement of the chemoembolization of hepatocellular carcinoma, which could also be extended to other clinical embolization treatments for blood-rich solid tumors.

UI MeSH Term Description Entries
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008422 Materials Testing The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility. Biocompatibility Testing,Biocompatible Materials Testing,Hemocompatibility Testing,Testing, Biocompatible Materials,Testing, Hemocompatible Materials,Hemocompatibility Testings,Hemocompatible Materials Testing,Materials Testing, Biocompatible,Materials Testing, Hemocompatible,Testing, Biocompatibility,Testing, Hemocompatibility,Testing, Materials,Testings, Biocompatibility
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Porous Pt nanoparticles loaded with doxorubicin to enable synergistic Chemo-/Electrodynamic Therapy.
October 2020, Biomaterials,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
A synergistic combination therapy with paclitaxel and doxorubicin loaded micellar nanoparticles.
April 2014, Colloids and surfaces. B, Biointerfaces,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Dual Carfilzomib and Doxorubicin-Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma.
July 2016, Molecular cancer therapeutics,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Micellar nanoparticles loaded with gemcitabine and doxorubicin showed synergistic effect.
January 2014, Colloids and surfaces. B, Biointerfaces,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Lactobionic acid-modified phycocyanin nanoparticles loaded with doxorubicin for synergistic chemo-photodynamic therapy.
September 2021, International journal of biological macromolecules,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Multifunctional nanoparticles for trimodal photodynamic therapy-mediated photothermal and chemotherapeutic effects.
September 2018, Photodiagnosis and photodynamic therapy,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy.
October 2012, Journal of controlled release : official journal of the Controlled Release Society,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Doxorubicin-Fe(III)-Gossypol Infinite Coordination Polymer@PDA:CuO2 Composite Nanoparticles for Cost-Effective Programmed Photothermal-Chemodynamic-Coordinated Dual Drug Chemotherapy Trimodal Synergistic Tumor Therapy.
July 2023, ACS nano,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Cyclo-γ-polyglutamic acid-coated dual-responsive nanomicelles loaded with doxorubicin for synergistic chemo-photodynamic therapy.
September 2021, Biomaterials science,
Minjiang Chen, and Xiaoling Xu, and Gaofeng Shu, and Chenying Lu, and Jiahui Wu, and Xiuling Lv, and Jingjing Song, and Fazong Wu, and Chunmiao Chen, and Nannan Zhang, and Yuyin Du, and Jun Wang, and Min Xu, and Shiji Fang, and Qiaoyou Weng, and Yiling Zhu, and Yuan Huang, and Zhongwei Zhao, and Yongzhong Du, and Jiansong Ji
Dual-Stimuli Responsive Nanotheranostics for Multimodal Imaging Guided Trimodal Synergistic Therapy.
February 2017, Small (Weinheim an der Bergstrasse, Germany),
Copied contents to your clipboard!